Search clinical trials for: Safety, Immunogenicity, Quadrivalent influenza vaccine

Total 11202 results

Sanofi Pasteur, a Sanofi Company

Completed

Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)

Meningococcal Immunisation (Healthy Volunteers)

United States, Puerto Rico
Sanofi Pasteur, a Sanofi Company

Completed

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers

Meningococcal Immunisation (Healthy Volunteers)

Denmark, Finland, Germany
University of Pennsylvania

Active, not recruiting

Flu Vaccine Responses in the Setting of Melanoma Treatment

Viral Vaccines

United States
Yale University
Centers for Disease Control and Prevention

Completed

Assessment, Feedback, Incentive, Exchange (AFIX OB) A Customizable Quality Improvement Intervention to Increase Maternal Vaccine Uptake (AFIX-OB)

Whooping Cough | Influenza

United States
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Flu2Text: Text Message Reminders for 2nd Dose of Influenza Vaccine (F2T)

Influenza | Vaccination

United States
Osivax
Center for vaccinology (CEVAC), University of Ghent

Completed

Immunogenicity and Safety of Three Dose Levels of OVX836 Candidate Vaccine Against Influenza in Healthy Volunteers.

Influenza

Belgium
Alexion
Achillion, a wholly owned subsidiary of Alexion

Completed

Elvucitabine/Efavirenz/Tenofovir Versus Lamivudine/Efavirenz/Tenofovir in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-naive Participants

HIV Infections

United States, Puerto Rico
Memorial Sloan Kettering Cancer Center

Active, not recruiting

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Childhood Cancer | Multiple Diseases

United States
The Archer-Daniels-Midland Company
NIZO Food Research

Completed

Probiotics and Influenza Vaccination Response (VERB)

Vaccine Response

Netherlands
Materia Medica Holding

Completed

Clinical Study of Efficacy and Safety of Raphamin in the Treatment of ARVI in Children 12-18 Years Old

Acute Respiratory Viral Infection

Russian Federation
University of Miami
Florida Department of Health

Active, not recruiting

VSMART (Video-Conference Stress Management and Relaxation Training for Older Women With Breast Cancer) (VSMART)

Stress

United States
Seqirus

Completed

A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed

Infections | RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza, Human | Orthomyxoviridae Infections | Influenza in Birds

United States
National Bureau of Economic Research, Inc.
National Institute on Aging (NIA); Massachusetts Institute of Technology; Geisinger...

Completed

Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake

Influenza | Health Promotion | Health Behavior | Risk Reduction | Vaccination

United States
Shanghai Bovax Biotechnology Co., Ltd.

Terminated

A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females

Cervical Cancer | CIN1 | CIN2 | CIN3 | Genital Wart | AIS | Vain I | Vain III | Vin I | Vin II | Vin III | VAIN - Vaginal Intraepithelial Neoplasia 2

China
Stanford University
National Institutes of Health (NIH); Doris Duke Charitable Foundation

Terminated

NK Cell Mediated Influenza Immunity During Pregnancy (Flu vaccine)

Pregnancy Related | Influenza, Human

United States
Vietnam Military Medical University
Vietstar Biomedical Research; Institute of Vaccines and Medical Biologicals...

Completed

This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam

Influenza

Vietnam
Radboud University Medical Center
GlaxoSmithKline

Completed

Age Differences in Influenza and Herpes Zoster Vaccine Responses (INFLUENZA-SHINGRIX)

Influenza | Herpes Zoster

Netherlands
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly With Influenza Vaccine in Adults 50 Years of Age or Older (V116-005, STRIDE-5)

Pneumonia, Pneumococcal

United States
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Food and Drug... and other collaborators

Active, not recruiting

A Pragmatic Assessment of Influenza Vaccine Effectiveness in the DoD (PAIVED)

Influenza | Influenza-like Illness | Influenza Vaccines

United States
Medicago

Completed

Efficacy of a Plant-derived Quadrivalent Virus-like Particle (VLP) Vaccine in the Elderly

RNA Virus Infections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases

United States, Canada, Finland, Germany, Thailand
Robert J. Pignolo
Genome Protection, Inc

Completed

Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination

Healthy

United States
AstraZeneca
Amgen

Completed

Study to Assess the Effect of Tezepelumab on the Immune Response to Influenza Vaccination in Participants With Asthma (VECTOR)

Moderate to Severe Asthma

United States
China National Biotec Group Company Limited
Beijing Institute of Biological Products Co Ltd.

Active, not recruiting

A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed (DTaP)

Whooping Cough | Tetanus | Diphtheria

China
CanSino Biologics Inc.
Beijing Institute of Biotechnology

Completed

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

COVID-19

Mexico, Argentina, Chile, Pakistan, Russian Federation
FluGen Inc
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old

Influenza Vaccine

United States
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Completed

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Coronavirus Disease 2019

China
Tor Biering-Sørensen
Sanofi Pasteur, a Sanofi Company; Statens Serum Institut

Completed

Nationwide Utilization of Danish Government Electronic Letter System for Increasing InFLUenza Vaccine Uptake (NUDGE-FLU)

Influenza | Behavior and Behavior Mechanisms

Denmark
CureVac
GlaxoSmithKline

Completed

A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

Influenza

Panama
Roswell Park Cancer Institute

Completed

Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United States
Mahidol University
Chulalongkorn University; National Cancer Institute, Thailand; Siriraj Hospital; National Vaccine Institute, Thailand and other collaborators

Completed

Effectiveness of HPV Vaccine in Thai Adult Women

Uterine Cervical Dysplasia | Papillomavirus Vaccines

Thailand
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Immunogenicity of HPV (Human Papilloma Virus) Vaccine in Healthy Females 9 to 15 Years of Age in India (V501-029)

Papillomavirus Infections
George Washington University

Completed

Immune Response to Seasonal Influenza Vaccine in HIV Infected Individuals

Influenza, Human | Human Immunodeficiency Virus I Infection

United States
ModernaTX, Inc.

Active, not recruiting

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

Seasonal Influenza

United States
Mayo Clinic
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Gene Signatures of Influenza Vaccine Responses in Older Adults

Influenza

United States
University of California, Los Angeles
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Patient Portal Flu Vaccine Reminders (5)

Respiratory Tract Infections | Influenza

United States
Novavax

Completed

Phase 3 Pivotal Trial of NanoFlu™ in Older Adults

Influenza, Human

United States
Novartis Vaccines

Completed

Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012

Seasonal Influenza

Italy
National Cancer Institute (NCI)

Active, not recruiting

Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial

Human Papillomavirus-Related Cervical Carcinoma

Costa Rica
Livzon Pharmaceutical Group Inc.

Active, not recruiting

Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (COVID-19)

COVID-19 Pandemic

Philippines, Indonesia, Russian Federation
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

The Influence of Chronic CMV Infection on Influenza Vaccine Responses (SLVP025)

Influenza | Cytomegalovirus Infections

United States
University of British Columbia
Ministry of Health, British Columbia

Completed

Evaluation of Therapeutic Initiative's Cystitis Portrait and Therapeutics Letter

Quality Improvement | Clinical Audit

Canada
Immunovative Therapies, Ltd.
Mirror Biologics, Inc.

Completed

Universal Anti-Viral Vaccine for Healthy Elderly Adults (ALLOPRIME)

Virus Diseases | Pneumonia | Influenza, Human | COVID-19 Respiratory Infection | ARDS, Human | RSV Pneumonia

United States
Novavax

Completed

A Study Looking at the Effectiveness, Immune Response, and Safety of a COVID-19 Vaccine in Adults in the United Kingdom

COVID-19 | SARS-CoV-2 Infection

United Kingdom
Butantan Institute

Completed

Effectiveness Assessment of Vaccinating Schoolchildren Against Influenza (Xo_Gripe)

Influenza | Acute Respiratory Infection

Brazil
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Infectious Diseases...

Completed

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

HIV Infections | Influenza

United States
Insight Therapeutics, LLC
Brown University; Seqirus

Completed

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

Influenza | Influenza, Human | Influenza-like Illness

United States
Insight Therapeutics, LLC
Brown University; Case Western Reserve University; Seqirus

Completed

Adjuvanted Influenza Vaccination in U.S. Nursing Homes

Influenza | Influenza-like Illness

United States
BiondVax Pharmaceuticals ltd.

Completed

A Double-Dose Safety Study of An Influenza Vaccine (Multimeric-001)

Healthy

Israel
Shire
Takeda Development Center Americas, Inc.

Completed

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Cytomegalovirus (CMV)

United States, China, Spain, Belgium, Australia, Germany, Italy, Canada, France, Croatia, Singapore, United Kingdom, New Zealand, Korea, Republic of, Russian Federation, Poland, Austria, Greece, Switzerland, Czechia, Hungary, Israel, Turk...
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Active, not recruiting

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)

Acute Gastroenteritis

China

Search clinical trials for: Safety, Immunogenicity, Quadrivalent influenza vaccine

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Papua New Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations